Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

eHealth (EHTH) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for eHealth (EHTH) over the last 17 years, with Q3 2025 value amounting to $63.1 million.

  • eHealth's Cash & Equivalents fell 147.27% to $63.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $63.1 million, marking a year-over-year decrease of 147.27%. This contributed to the annual value of $39.2 million for FY2024, which is 6612.83% down from last year.
  • Latest data reveals that eHealth reported Cash & Equivalents of $63.1 million as of Q3 2025, which was down 147.27% from $65.9 million recorded in Q2 2025.
  • eHealth's 5-year Cash & Equivalents high stood at $229.3 million for Q2 2021, and its period low was $39.2 million during Q4 2024.
  • Its 5-year average for Cash & Equivalents is $133.5 million, with a median of $144.4 million in 2022.
  • As far as peak fluctuations go, eHealth's Cash & Equivalents surged by 19835.25% in 2021, and later crashed by 6612.83% in 2024.
  • Over the past 5 years, eHealth's Cash & Equivalents (Quarter) stood at $81.9 million in 2021, then soared by 76.26% to $144.4 million in 2022, then fell by 19.86% to $115.7 million in 2023, then plummeted by 66.13% to $39.2 million in 2024, then surged by 60.95% to $63.1 million in 2025.
  • Its last three reported values are $63.1 million in Q3 2025, $65.9 million for Q2 2025, and $121.1 million during Q1 2025.